Bustamante, Wendy Lyn C.

HRN: 16-88-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2022
CEFUROXIME 1.5GM (VIAL)
07/01/2022
07/08/2022
IVT
1300mg
Q8h
UTI, PCAP-B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: